Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04636346 · ClinicalTrials.gov registry record
COMPASS: A Group ACT Program for Cancer Patients Treated at UCSF
A clinical trial, sponsored by University of California, San Francisco.
- Completed
- Registry status
- 129
- Enrollment target
NCT04636346: Completed study, sponsored by University of California, San Francisco.
NCT04636346 is a clinical trial that has completed, run by University of California, San Francisco. The registered enrollment target is 129 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04636346 has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- 129 participants
- Enrollment target
Study Summary
Cancer Center Psychosocial services (Psycho-Oncology) offers group psychoeducational and behavioral programs as part of its clinical service for cancer patients and services at the Helen Diller Family Comprehensive Cancer Center. Clinical outcomes and acceptability/feasibility and implementation process data from these programs are routinely gathered in an effort to engage in continuous quality improvement for the department.
Primary Outcome
The PROMIS Anxiety Short form consists of 2 items addressing patient anxiety with item response scores ranging from 1 (never) to 5 (Always). Raw scores are converted to scaled T-scores with higher scores indicating a greater level of anxiety. Significant changes over time and trends in patient reported outcomes will be analyzed via student's T-test.
Interventions
- OTHER Questionnaires
- BEHAVIORAL Acceptance and Commitment Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 129 participants |
| Start Date | 2020-03-24 |
| Est. Completion | 2020-12-14 |
What the finished NCT04636346 record still lists
NCT04636346 is an observational study that tracks outcomes without assigning an intervention. The registered 129 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which Questionnaires is the first listed.
NCT04636346 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04636346 about?
NCT04636346 is a clinical study titled "COMPASS: A Group ACT Program for Cancer Patients Treated at UCSF". Cancer Center Psychosocial services (Psycho-Oncology) offers group psychoeducational and behavioral programs as part of its clinical service for cancer patients and services at the Helen Diller Family Comprehensive Cancer Center. Clinical outcomes and acceptability/feasibility and implementation pro...
What is the current status of trial NCT04636346?
This trial is currently completed. The enrollment target is 129 participants. The study started on 2020-03-24. Estimated completion is 2020-12-14.
What interventions are being tested in trial NCT04636346?
The interventions under investigation include: Questionnaires (OTHER), Acceptance and Commitment Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT04636346?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03619850 · 129 participants · Phase 3
A Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects With Chronic Kidney Disease (CKD)
- NCT05704361 · 129 participants · Phase 1
A Study to Investigate the Safety, Tolerability, and Processing by the Body of Intravenous and Subcutaneous RO7121932 Administration in Participants With Multiple Sclerosis
- NCT05919849 · 129 participants · Phase 1
Supporting Parents in Affirming Their Children's Experiences of Stigma
- NCT06313749 · 129 participants · NA
Safety and Effectiveness of Minimally Invasive Micro Sclerostomy (MIMS®) to Reduce Intraocular Pressure in Open-Angle Glaucoma Which is Not Controlled Despite Polypharmacy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI